One by One-Teva Your up next, Swing for the Fences!

One-by-one, my stock pick(s) will begin to come to fruition. With my stock pick of Ebay up over 14% (after hours) since my selection of it, people should think to themselves...Hmm...Does this 18-year-old investor actually know what he is talking about? If, you still think I am not worthy of your money or time, here is my next stock pick of the week! Which stock could it possibly be? TEVA is the chosen one! This Israeli high-powered generic firm has annual revenue of over five-billion dollars. They also have developed a drug that is the leader in its field for MS called Copaxone. They have had sales in the second quarter of $291 million, up 29% a year ago. Besides for this, they currently are trying to develop a drug for Parkinson's disease and an oral treatment for MS. They also have a ton of generic drugs developed and sold in the U.S and have a strong pipeline of approximately 80 drugs that are set to be filed for FDA approval by 2007, according to an article read on Forbes.com, gearing them for the coming future. My price target is $41, from the current level of $30.97.